Literature DB >> 6392656

Eradication of microscopic metastases with intratumoral injection of bacillus Calmette-Guerin.

M Sakita, A Takenaka, T Yamane, M Kasuga, Y Fujita, S Majima.   

Abstract

The studies reported here were designed to examine the effects of intratumoral preoperative administration of Bacillus Calmette-Guerin (BCG) on the cure rates of C3H mice transplanted with MH134 tumor cells and on the metastatic rates in the regional lymph nodes. Furthermore, the morphological findings occurring in the regional lymph nodes were monitored during tumor growth using H-E stain and non-specific esterase staining. The cure rate of the Group treated with BCG intratumoral injection and surgery was significantly higher than that of the Group treated with surgery alone, and in the BCG + surgery group metastatic rates of regional lymph nodes decreased consistently after operation. Moreover, in this group, extensive sinus histiocytosis and marked swelling of the regional nodes were frequently observed. Quantitative studies of the cell kinds using the esterase staining indicated that intratumoral injection of BCG has an effect on the influx of lymphoid cells into the regional nodes, but does not aid specific cell lineage to flow into the regional nodes. In cytostatic assays, it was shown that the regional lymph node cells and spleen cells in the BCG + surgery group always have a greater per cent of inhibition than those in the surgery alone group.

Entities:  

Mesh:

Year:  1984        PMID: 6392656     DOI: 10.1007/BF02469551

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  10 in total

1.  Identification of human mononuclear leucocyte populations by esterase staining.

Authors:  D A Horwitz; A C Allison; P Ward; N Kight
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

2.  Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.

Authors:  M G Hanna; B Zbar; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-05       Impact factor: 13.506

3.  Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis.

Authors:  B Zbar; I D Bernstein; G L Bartlett; M G Hanna; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-07       Impact factor: 13.506

4.  BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.

Authors:  J Gutterman; G Mavligit; C McBride; E Frei; E M Hersh
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

5.  Regional lymphadenectomy and tumor curability in C3H/He mice transplanted with MH 134.

Authors:  M Sakita; Y Nishimura; A Takenaka; O Kojima; B Nishioka; Y Fujita; S Majima
Journal:  Tohoku J Exp Med       Date:  1979-02       Impact factor: 1.848

6.  Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines.

Authors:  J E Sokal; C W Aungst; T Han
Journal:  Cancer Res       Date:  1972-07       Impact factor: 12.701

Review 7.  Immunological factors which influence response to immunotherapy in malignant melanoma.

Authors:  D Morton; F R Eilber; R A Malmgren; W C Wood
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

8.  Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor.

Authors:  M G Hanna; L C Peters
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

9.  Regional immunotherapy of lung cancer with intrapleural B.C.G.

Authors:  M F McKneally; C Maver; H W Kausel
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

10.  Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.

Authors:  B Zbar; T Tanaka
Journal:  Science       Date:  1971-04-16       Impact factor: 47.728

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.